2160

GNI Group
2160

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
¥172.48B
EV
¥171.74B
Shares Outstanding
50.21M
Beta
1.38

Wall Street View

Analyst Rating
BUY
Analyst Target Price
¥4500.00
P/E 2025E
12.84x
P/Revenue 2025E
5.90x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About GNI Group Ltd.

gainify
2160

GNI Group Ltd.

2160

GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinica...

Sector

Healthcare

Industry

Biotechnology

CEO

Luo, Ying

Employees

867

IPO Date

2007-08-31

Headquarters

Nihonbashi-Honcho YS Building, 3rd Floor, 2-2-2 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-0023, Japan

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.